Involvement of granzyme B expression in the enhancement of natural killer activity by β-endorphin

Brain, Behavior, and Immunity

Volumn 14, Issue 1, 2000, Pages 27-40

  Wakao, Keiko ^a   Matsuzaki, Ichiyo ^b   Terao, Keiji ^c   Inoue Murayama, Miho ^a   Shimojo, Nobuhiro ^a   Murayama, Yuichi ^d  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Tsukuba Primate Ctr for Med Sci   (Japan)

^c GIFU UNIVERSITY   (Japan)

^d NATIONAL INSTITUTE OF ANIMAL HEALTH   (Japan)

Author keywords

Fas ligand; Granzyme B; NK cell; Opioid peptide; Perforin

Indexed keywords

BETA ENDORPHIN; CD16 ANTIGEN; FAS LIGAND; GRANZYME B; PERFORIN;

ADULT; ARTICLE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MALE; NATURAL KILLER CELL; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0034088192     PISSN: 08891591     EISSN: None     Source Type: Journal    
DOI: 10.1006/brbi.1999.0568     Document Type: Article

References (61)

1. Arase H., Arase N., Saito T. Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 181:1995;1235-1238.
2. Aste-Amezaga M., D'Andrea A., Kubin M., Trinchieri G. Cooperation of natural killer cell stimulatory factor/interleukin-12 with other stimuli in the induction of cytokines and cytotoxic cell-associated molecules in human T and NK cells. Cell. Immunol. 156:1994;480-492.
3. Belkowski S. M., Zhu J., Liu-Chen L. Y., Eisenstein T. K., Adler M. W., Rogers T. J. Sequence of κ-opiod receptor cDNA in the R1.1 thymoma cell line. J. Neuroimmunol. 62:1995;113-117.
4. Bessler H., Sztein M. B., Serrate S. A. β-endorphin modulation of IL-1-induced IL-2 production. Immunopharmacology. 19:1990;5-14.
5. Brown S. L., Van Epps D. E. Opioid peptides modulate production of interferon. Cell. Immunol. 103:1986;19-26.
6. Carpenter G. W., Garza H. H., Gebhardt B. M., Carr D. J. J. Chronic morphine treatment supresses CTL-mediated cytolysis, granulation and cAMP responses to alloantigen. Brain Behav. Immun. 8:1994;185-203.
7. Carr D. J. J. The role of endogenous opioids and their receptors in the immune system. Proc. Soc. Exp. Biol. Med. 198:1991;710-720.
8. Carr D. J. J., Mayo S., Gebhardt B. M., Porter J. Central alpha-adrenergic involvement in morphine-mediated suppression of splenic natural killer activity. J. Neuroimmunol. 53:1994;53-63.
9. Chehimi J., Starr S. E., Frank I., Rengaraju M., Jackson S. J., Llanes C., Kobayashi M., Perussia B., Young D., Nickbarg E., Wolf S. F., Trinchieri G. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients. J. Exp. Med. 175:1992;789-796.
10. Chiappelli F., Yamashita N., Faisal M., Kemeny M., Bullington R., Nguyen L., Clement L. T., Fahey J. L. Differential effects of beta-endorphin on three human cytotoxic cell populations. Int. J. Immunopharmac. 13:1991;291-297.
11. Chiappelli F., Kavelaars A., Heijnen C. J. β-Endorphin effects on membrane transduction in human lymphocytes. Ann. N. Y. Acad. Sci. 650:1992;211-217.
12. Chuang L. F., Chuang T. K., Killam K. F. Jr., Chuang A. J., Kung H.-F., Yu L., Chuang R. Y. Delta opiod receptor gene expression in lymphocytes. Biochem. Biophys. Res. Commun. 202:1994;1291-1299.
13. Chuang T. K., Killam K. F. Jr., Chuang L. F., Kung H.-F., Sheng W. S., Chao C. C., Yu L., Chuang R. Y. Mu opioid receptor gene expression in immune cells. Biochem. Biophys. Res. Commun. 216:1995;922-930.
14. Colonna M., Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science. 268:1995;405-408.
15. Cosulich M. E., Rubartelli A., Risso A., Cozzolino F., Bargellesi A. Functional characterization of an antigen involved in an early step of T-cell activation. Proc. Natl. Acad. Sci. USA. 84:1987;4205-4209.
16. Dahl C. A., Bach F. H., Chan W., Huebner K., Russo G., Croce C. M., Herfurth T., Cairns J. S. Isolation of a cDNA clone encoding a novel form of granzyme B from human NK cells and mapping to chromosome 14. Hum. Genet. 84:1990;465-470.
17. Darmon A. J., Nicholson D. W., Bleackley R. C. Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature. 377:1995;446-448.
18. DeBlaker-Hohe D. F., Yamauchi A., Yu C.-R., Horvarth-Arcidiacono J. A., Bloom E. T. IL-12 synergizes with IL-2 to induce lymphokine-activated cytotoxicity and perforin and granzyme gene expression in fresh human NK cells. Cell. Immunol. 165:1995;33-43.
19. De Sanctis G., De Carolis C., Moretti C., Perricone R., Fabbri A., Gnessi L., Fraioli F., Fontana L. Endogenous opioids and the immune system: Demonstration of inhibiting as well as enhancing effects of beta-endorphin on natural killer activity. Riv. Immun. Immunofarmac. 6:1986;13-15.
20. Ellis T. M., McKenzie R. S., Simms P. E., Helfrich B. A., Fisher R. I. Induction of human lymphokine-activated killer cells by IFN-alpha and IFN-gamma. J. Immunol. 143:1989;4282-4286.
21. Freier D. O., Fuchs B. A. A mechanism of action for morphine-induced immunosuppression: Corticosterone mediates morphine-induced suppression of natural killer activity. J. Pharmacol. Exp. Ther. 270:1994;1127-1133.
22. Froelich C. J., Bankhurst A. D. The effect of β-endorphin on natural cytotoxicity and antibody dependent cellular cytotoxicity. Life Sci. 35:1984;261-265.
23. Furuhashi N., Takahashi Y., Kono H., Shinkawa O., Fukaya T., Suzuki M. Sex difference in the human peripheral plasma beta-endorphin and beta-lipotropin levels. Gynecol. Obstet. Invest. 17:1988;145-148.
24. Gerosa F., Tommasi M., Benati C., Gandini G., Libonati M., Tridente G., Carra G., Trinchieri G. Differential effects of tyrosine kinase inhibition in CD69 antigen expression and lytic activity induced by rIL-2, rIL-12, and rIFN-alpha in human NK cells. Cell. Immunol. 150:1993;382-390.
25. Gilmore W., Weiner L. P. β-Endorphin enhances IL-2 production in murine lymphocytes. J. Neuroimmunol. 18:1988;125-138.
26. Grimm E. A., Mazumder A., Zhang H. Z., Rosenberg S. A. Lymphokine-activated killer cell phenomenon: Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes. J. Exp. Med. 155:1982;1823-1841.
27. Hanson R. D., Grisolano J. L., Ley T. J. Consensus AP-1 and CRE motifs upstream from the human cytotoxic serine protease B (CSP-B/CGL-1) gene synergize to activate transcription. Blood. 82:1993;2749-2757.
28. Hara T., Jung L. K., Bjorndahl J. M., Fu S. M. Human T cell activation. III. Rapid induction of a phosphorylated 28 kD/32 kD disulfide-linked early activation antigen (EA 1) by 12-o-tetradecanoyl phorbol-13-acetate, mitogen, and antigens. J. Exp. Med. 164:1986;1988-2005.
29. Hazum E., Chang K. J., Cuatrecasa P. Specific nonopiate receptors for β-endorphin. Science. 205:1979;1033-1035.
30. Heusel J. W., Wesselschmidt R. L., Shresta S., Russell J. H., Ley T. J. Cytotoxic lymphocytes require granzyme b for the rapid induction of DNA fragmentation and apoptosis in allogenic target cells. Cell. 76:1994;977-987.
31. Ikura S., Terao K., Matsuzaki I., Inoue-Murayama M., Murayama Y. U5 monoclonal antibody identifies a novel lymphocyte surface antigen preferentially expressed in human circulating natural killer cells with high cytotoxic activity. Immunology. 96:1999;485-490.
32. Kägi D., Ledermann B., Bürki K., Seiler P., Odermatt B., Olsen K. J., Podack E. R., Zinkernagel R. M., Hengartner H. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature. 369:1994;31-37.
33. Kavelaars A., Ballieux R. E., Heijnen C. J. Differential effects of beta-endorphin on cAMP levels in human peripheral blood mononuclear cells. Brain Behav. Immun. 4:1990;171-179.
34. Kay N., Allen J., Morley J. E. Endorphin stimulates normal human peripheral blood lymphocyte natural killer activity. Life Sci. 35:1984;53-59.
35. Klein J. L., Shows T. B., Dupont B., Trapani J. A. Genomic organization and chromosomal assignment for a serine protease gene (CSPB) expressed by human cytotoxic lymphocytes. Genomics. 5:1989;110-117.
36. Kroesen B.-J., Mesander G., ter Haar J. G., The T. H., de Leij L. Direct visualization and quantification of cellar cytotoxicity using two colour fluorescence. J. Immunol. Methods. 156:1992;47-54.
37. Lazebnik Y. A., Takahashi A., Moir R. D., Goldman R. D., Poirier G. G., Kaufmann S. H., Earnshaw W. C. Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc. Natl. Acad. Sci. USA. 92:1995;9042-9046.
38. Levy S. M., Fernstrom J., Herberman R. B., Whiteside T., Lee J., Ward M., Massoudi M. Persistently low natural killer cell activity and circulating levels of plasma beta-endorphin: Risk factors for infectious disease. Life Sci. 48:1991;107-116.
39. Liu C.-C., Walsh C. M., Eto H., Clark W. R., Young J. D.-E. Morphologic and functional characterization of perforin-deficient lymphokine-activated killer cells. J. Immunol. 155:1995a;602-608.
40. Liu C.-C., Walsh C. M., Young J. D.-E. Perforin: Structure and function. Immunol. Today. 16:1995b;194-201.
41. Mandler R. N., Biddison W. E., Mandler R., Serrate S. A. β-Endorphin augments the cytolytic activity and interferon production of natural killer cells. J. Immunol. 136:1986;934-938.
42. Mathews P. M., Froelich C. J., Sibbitt W. L. Jr., Bankhurst A. D. Enhancement of natural cytotoxicity by β-endorphin. J. Immunol. 130:1983;1658-1662.
43. McCain H. W., Lamstar I. B., Bozzone J. M., Grbic J. T. β-Endorphin modulates human immune activity via non opiate receptor mechanism. Life Sci. 31:1982;1619-1629.
44. Moretta A., Biassoni R., Bottino C., Pende D., Vitale M., Poggi A., Mingari M. C., Moretta L. Major histocompatibility complex class I-specific receptors on human natural killer and T lymphocytes. Immunol. Rev. 155:1997;105-117.
45. Murayama Y., Amano A., Mukai R., Shibata H., Matsunaga S., Takahashi H., Yoshikawa Y., Hayamai M., Noguchi A. CD4 and CD8 expressions in African green monkey helper T lymphocytes: Implication for resistance to SIV infection. Int. Immunol. 9:1997;843-851.
46. Nagata S., Suda T. Fas and Fas ligand: lpr and gld mutations. Immunol. Today. 16:1995;39-43.
47. Nagler A., Lanier L. L., Cwirla S., Phillips J. H. Comparative studies of human FcRIII-positive and negative natural killer cells. J. Immunol. 143:1989;3183-3191.
48. Nguyen Q. H., Roberts R. L., Ank B. J., Lin S. J., Thomas E. K., Stiehm E. R. Interleukin (IL)-15 enhances antibody-dependent cellular cytotoxicity and natural killer activity in neonatal cells. Cell. Immunol. 185:1998;83-92.
49. Oleson D. R., Johnson D. R. Regulation of human natural cytotoxicity by enkephakins and selective opiate agonists. Brain Behav. Immun. 2:1988;171-186.
50. Phillips J. H., Lanier L. L. Dissection of the lymphokine-activated killer phenomenon: Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis. J. Exp. Med. 164:1986;814-825.
51. Robertson M. J., Soiffer R. J., Wolf S. F., Manley T. J., Donshue C., Young D., Herrmann S. H., Ritz J. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): Cytolytic activity and proliferation of NK cells are differentially regulated by NKSF. J. Exp. Med. 175:1992;779-788.
52. Salcedo T. W., Azzoni L., Wolf S. F., Perussia B. Modulation of perforin and granzyme messenger RNA expression in human natural killer cells. J. Immunol. 151:1993;2511-2520.
53. Schlegel J., Peters I., Orrenius S., Miller D. K., Thornberry N. A., Yamin T. T., Nicholson D. W. CPP32/apopain is a key interleukin 1 beta converting enzyme-like protease involved in Fas-mediated apoptosis. J. Biol. Chem. 271:1996;1841-1844.
54. Sharp B. M., Eisenstein T. Expression of opioid receptor by immune cells. J. Neuroimmunol. 69:1996;3-13.
55. Shresta S., Maclvor D. M., Heusel J. W., Russell J. H., Ley T. J. Natural killer and lymphokine-activated killer cells require granzyme B for the rapid induction of apoptosis in susceptible target cells. Proc. Natl. Acd. Sci. USA. 92:1995;5679-5683.
56. Sibinga N. E. S., Goldstein A. Opioid peptides and opioid receptors in cells of immune system. Annu. Rev. Immunol. 6:1988;219-249.
57. Smyth M. J., Trapani J. A. Granzyme: Exogenous proteinases that induce target cell apoptosis. Immunol. Today. 16:1995;202-206.
58. Suda T., Nagata S. Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179:1994;873-879.
59. Van Den Bergh P., Rozing J., Nagelkerken L. Two opposing modes of action of beta-endorphin on lymphocyte function. Immunology. 72:1991;537-543.
60. Van Epps D. E., Saland L. β-Endorphin and met-enkephalin stimulate human peripheral blood mononuclear cell chemotaxis. J. Immunol. 132:1984;3046-3053.
61. Wargnier A., Legros-Maida S., Bosselut R., Bourge J. F., Lafaurie C., Ghysdael C. J., Sasportes M., Paul P. Identification of human granzyme B promoter regulatory elements interacting with activated T-cell-specific proteins: Implication of Ikaros and CBF binding sites in promoter activation. Proc. Natl. Acad. Sci. USA. 92:1995;6930-6934.